Cargando…
Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction
BACKGROUND: Acute myocardial infarction (AMI) is the most serious type of heart disease. Clinically, there is an urgent need to discover diagnostic biomarkers for the early diagnosis of AMI. METHODS: Serum proteomic profiles in AMI patients, healthy controls, and stable angina pectoris (SAP) patient...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246203/ https://www.ncbi.nlm.nih.gov/pubmed/34268356 http://dx.doi.org/10.21037/atm-20-7891 |
_version_ | 1783716265202810880 |
---|---|
author | Shi, Li-Ying Han, Yu-Shuai Chen, Jing Li, Zhi-Bin Li, Ji-Cheng Jiang, Ting-Ting |
author_facet | Shi, Li-Ying Han, Yu-Shuai Chen, Jing Li, Zhi-Bin Li, Ji-Cheng Jiang, Ting-Ting |
author_sort | Shi, Li-Ying |
collection | PubMed |
description | BACKGROUND: Acute myocardial infarction (AMI) is the most serious type of heart disease. Clinically, there is an urgent need to discover diagnostic biomarkers for the early diagnosis of AMI. METHODS: Serum proteomic profiles in AMI patients, healthy controls, and stable angina pectoris (SAP) patients were explored and compared by iTRAQ-2DLC-MS/MS. The clinical data of AMI patients were also analyzed. Differentially expressed proteins were validated by enzyme linked immunosorbent assay (ELISA), and diagnostic models were constructed. RESULTS: A total of 39 differentially expressed proteins were identified in AMI patients. The results showed that the serum levels of apolipoprotein E (APOE) in AMI patients were notably higher than those in the healthy controls (P=0.0172). The serum levels of aspartate aminotransferase (AATC) in AMI patients were markedly higher than those in the healthy controls and SAP patients (P<0.0001 and P<0.0001, respectively). The serum levels of fibronectin (FINC) in SAP patients were significantly higher than those in the healthy controls and AMI patients (P=0.0043 and P=0.0044, respectively). Clinical data analysis showed a considerable difference in blood glucose levels, troponin I (TNI), and creatine kinase (CK) in AMI patients compared with SAP patients and healthy controls. A diagnostic model consisting of AATC and clinical indicators [lactate dehydrogenase (LDH) and CK] was established to distinguish between AMI patients and healthy controls, with an area under the curve (AUC) value of 0.993 sensitivity and specificity of 96.2% and 96.3%, respectively. A diagnostic model consisting of AATC and CK was established to distinguish between AMI patients and SAP patients, with an AUC value of 0.975 and a sensitivity and specificity of 85.2% and 79.30%, respectively. CONCLUSIONS: In this study, differentially expressed proteins in AMI patients were combined with clinical indexes, LDH and CK, and two diagnostic models were constructed. This study may provide meaningful data for the early diagnosis of AMI. |
format | Online Article Text |
id | pubmed-8246203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-82462032021-07-14 Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction Shi, Li-Ying Han, Yu-Shuai Chen, Jing Li, Zhi-Bin Li, Ji-Cheng Jiang, Ting-Ting Ann Transl Med Original Article BACKGROUND: Acute myocardial infarction (AMI) is the most serious type of heart disease. Clinically, there is an urgent need to discover diagnostic biomarkers for the early diagnosis of AMI. METHODS: Serum proteomic profiles in AMI patients, healthy controls, and stable angina pectoris (SAP) patients were explored and compared by iTRAQ-2DLC-MS/MS. The clinical data of AMI patients were also analyzed. Differentially expressed proteins were validated by enzyme linked immunosorbent assay (ELISA), and diagnostic models were constructed. RESULTS: A total of 39 differentially expressed proteins were identified in AMI patients. The results showed that the serum levels of apolipoprotein E (APOE) in AMI patients were notably higher than those in the healthy controls (P=0.0172). The serum levels of aspartate aminotransferase (AATC) in AMI patients were markedly higher than those in the healthy controls and SAP patients (P<0.0001 and P<0.0001, respectively). The serum levels of fibronectin (FINC) in SAP patients were significantly higher than those in the healthy controls and AMI patients (P=0.0043 and P=0.0044, respectively). Clinical data analysis showed a considerable difference in blood glucose levels, troponin I (TNI), and creatine kinase (CK) in AMI patients compared with SAP patients and healthy controls. A diagnostic model consisting of AATC and clinical indicators [lactate dehydrogenase (LDH) and CK] was established to distinguish between AMI patients and healthy controls, with an area under the curve (AUC) value of 0.993 sensitivity and specificity of 96.2% and 96.3%, respectively. A diagnostic model consisting of AATC and CK was established to distinguish between AMI patients and SAP patients, with an AUC value of 0.975 and a sensitivity and specificity of 85.2% and 79.30%, respectively. CONCLUSIONS: In this study, differentially expressed proteins in AMI patients were combined with clinical indexes, LDH and CK, and two diagnostic models were constructed. This study may provide meaningful data for the early diagnosis of AMI. AME Publishing Company 2021-05 /pmc/articles/PMC8246203/ /pubmed/34268356 http://dx.doi.org/10.21037/atm-20-7891 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Shi, Li-Ying Han, Yu-Shuai Chen, Jing Li, Zhi-Bin Li, Ji-Cheng Jiang, Ting-Ting Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction |
title | Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction |
title_full | Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction |
title_fullStr | Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction |
title_full_unstemmed | Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction |
title_short | Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction |
title_sort | screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246203/ https://www.ncbi.nlm.nih.gov/pubmed/34268356 http://dx.doi.org/10.21037/atm-20-7891 |
work_keys_str_mv | AT shiliying screeningandidentificationofpotentialproteinbiomarkersfortheearlydiagnosisofacutemyocardialinfarction AT hanyushuai screeningandidentificationofpotentialproteinbiomarkersfortheearlydiagnosisofacutemyocardialinfarction AT chenjing screeningandidentificationofpotentialproteinbiomarkersfortheearlydiagnosisofacutemyocardialinfarction AT lizhibin screeningandidentificationofpotentialproteinbiomarkersfortheearlydiagnosisofacutemyocardialinfarction AT lijicheng screeningandidentificationofpotentialproteinbiomarkersfortheearlydiagnosisofacutemyocardialinfarction AT jiangtingting screeningandidentificationofpotentialproteinbiomarkersfortheearlydiagnosisofacutemyocardialinfarction |